Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2200

David Epstein gets $140M for Ottimo's bifunctional take on hot PD-1xVEGF field

$
0
0
David Epstein has retired three times. And he quickly went to work when he got back in the saddle earlier this fall as CEO and chair of Ottimo Pharma, a preclinical biotech trying to take ...

Viewing all articles
Browse latest Browse all 2200

Trending Articles